halobetasol propionate and tazarotene (TBC) Last Updated: May 31, 2019 Result type: Reports Product Line: Common Drug Review Generic Name: halobetasol propionate and tazarotene Indications: Psoriasis, moderate to severe plaque Brand Name: TBCManufacturer: Bausch Health, Canada Inc. Project Number: SR0600-000Project Status: WithdrawnSubmission Type: New Details
insulin glargine (Semglee) Last Updated: May 31, 2019 Result type: Reports Product Line: Common Drug Review Generic Name: insulin glargine Indications: Diabetes mellitus, Type 1 & 2 Brand Name: SemgleeManufacturer: BGP PHARMA ULCProject Number: SE0589-000Project Status: WithdrawnSubmission Type: New Details
pegfilgrastim (Fulphila ) Last Updated: May 31, 2019 Result type: Reports Product Line: Common Drug Review Generic Name: pegfilgrastim Indications: Febrile neutropenia in non-myeloid malignancies Brand Name: Fulphila Manufacturer: BGP PHARMA ULCProject Number: SE0588-000 Project Status: CompleteSubmission Type: New Details
Trastuzumab Emtansine (Kadcyla) for Early Breast Cancer (EBC) — Details Last Updated: June 19, 2019 Result type: Reports Product Line: Pan Canadian Oncology Drug Review Project Number: pCODR 10182 Details
efinaconazole (Jublia) Last Updated: June 18, 2019 Result type: Reports Product Line: Common Drug Review Generic Name: efinaconazole Indications: Onychomycosis Brand Name: JubliaManufacturer: Bausch Health, Canada Inc. Project Number: SR0577-000Project Status: CompleteSubmission Type: New Details
cysteamine (Cystadrops) Last Updated: June 18, 2019 Result type: Reports Product Line: Common Drug Review Generic Name: cysteamine Indications: Corneal cystine crystal deposits Brand Name: CystadropsManufacturer: Recordati Rare Diseases Canada Inc.Project Number: SR0595-000 Project Status: ActiveSubmission Type: New Details
semaglutide (Ozempic) Last Updated: June 18, 2019 Result type: Reports Product Line: Common Drug Review Generic Name: semaglutide Indications: Diabetes mellitus, type 2 Brand Name: OzempicManufacturer: Novo Nordisk Canada Inc.Project Number: SR0594-000Project Status: CompleteSubmission Type: New Details
safinamide (Onstryv) Last Updated: June 17, 2019 Result type: Reports Product Line: Common Drug Review Generic Name: safinamide Indications: Parkinson's disease Brand Name: OnstryvManufacturer: Valeo Pharma Inc.Project Number: SR0617-000Project Status: ActiveSubmission Type: New Details
certolizumab pegol (Cimzia) Last Updated: June 18, 2019 Result type: Reports Product Line: Common Drug Review Generic Name: certolizumab pegol Indications: Psoriasis, moderate to severe plaque Brand Name: CimziaManufacturer: UCB Canada Inc.Project Number: SR0587-000Project Status: ActiveSubmission Type: NewIndication Details
Daratumumab (Darzalex) for Multiple Myeloma Last Updated: June 18, 2019 Result type: Reports Product Line: Pan Canadian Oncology Drug Review Project Number: pCODR 10189 Details
